General Information of the Compound
Compound ID
CP0503957
Compound Name
4-[[5-(2,3-dichlorophenyl)tetrazol-1-yl]methyl]-3,5-dimethyl-1,2-oxazole
    Show/Hide
Structure
Formula
C13H11Cl2N5O
Molecular Weight
324.171
Canonical SMILES
Cc1noc(C)c1Cn1nnnc1-c1cccc(Cl)c1Cl
    Show/Hide
InChI
InChI=1S/C13H11Cl2N5O/c1-7-10(8(2)21-17-7)6-20-13(16-18-19-20)9-4-3-5-11(14)12(9)15/h3-5H,6H2,1-2H3
    Show/Hide
InChIKey
NSFNYZATRUHKHQ-UHFFFAOYSA-N
Physicochemical Property
logP
3.30004
Rotatable Bonds
3
Heavy Atom Count
21
Polar Areas
69.63
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
6
Complexity
21

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 11652729
SID: 16756211
ChEMBL ID
CHEMBL378749
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01449, P2X purinoceptor 7
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000094 1321N1 Homo sapiens (Human)  1
1
IC50 = 158.49 nM
   TI
   LI
   LO
   TS